Home

Oren Gilad, President, CEO: Aprea Therapeutics APRE Buy · Filed 24/03/14

Trade details

Type
Insider buy
Amount
$14,580
Shares · price
2,000 sh · $7.29 a share
Held after
324,770 sh
Trade date
24/03/13
Filed
24/03/14
Days to filing
1 days

First buy since 2023

Insiders buying this week
4 insiders
Holding change
+0.6%

Aprea Therapeutics trades, last 26 weeks

What else happened in Aprea Therapeutics around then

Filed or reported within 30 days of the trade day · 24/02/12~24/04/12

Oren Gilad's recent trades

  • Oren Gilad

    BuyAprea Therapeutics

    $25K

    Filed 02/02

  • Oren Gilad

    BuyAprea Therapeutics

    $4,495

    Filed 25/04/04

  • Oren Gilad

    BuyAprea Therapeutics

    $5,616

    Filed 25/04/04

  • Oren Gilad

    BuyAprea Therapeutics

    $1,960

    Filed 24/10/24

  • Oren Gilad

    BuyAprea Therapeutics

    $725

    Filed 24/10/16